Why Ardelyx, Inc.’s (ARDX) Stock Is Up 7.17%

By Cynthia McLaughlin
November 27, 2025
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Ardelyx, Inc. before investing.

In this article, we go over a few key elements for understanding Ardelyx, Inc.’s stock price such as:

  • Ardelyx, Inc.’s current stock price and volume
  • Why Ardelyx, Inc.’s stock price changed recently
  • Upgrades and downgrades for ARDX from analysts
  • ARDX’s stock price momentum as measured by its relative strength

About Ardelyx, Inc. (ARDX)

Before we jump into Ardelyx, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Want to learn more about Ardelyx, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Ardelyx, Inc..

Learn More About A+ Investor

Ardelyx, Inc.’s Stock Price as of Market Close

As of November 26, 2025, 4:00 PM, CST, Ardelyx, Inc.’s stock price was $5.930.

Ardelyx, Inc. is up 3.67% from its previous closing price of $5.720.

During the last market session, Ardelyx, Inc.’s stock traded between $5.660 and $6.020. Currently, there are approximately 241.91 million shares outstanding for Ardelyx, Inc..

Ardelyx, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Ardelyx, Inc. Stock Price History

Ardelyx, Inc.’s (ARDX) price is currently down 2.15% so far this month.

During the month of November, Ardelyx, Inc.’s stock price has reached a high of $6.390 and a low of $5.300.

Over the last year, Ardelyx, Inc. has hit prices as high as $6.780 and as low as $3.210. Year to date, Ardelyx, Inc.’s stock is up 16.96%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Ardelyx, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 26, 2025, there was 1 analyst who downgraded Ardelyx, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Ardelyx, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Ardelyx, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Ardelyx, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Ardelyx, Inc. (ARDX) by visiting AAII Stock Evaluator.

Relative Price Strength of Ardelyx, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 26, 2025, Ardelyx, Inc. has a weighted four-quarter relative price strength of 1.39%, which translates to a Momentum Score of 64 and is considered to be Strong.

Want to learn more about how Ardelyx, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Ardelyx, Inc. Stock Price: Bottom Line

As of November 26, 2025, Ardelyx, Inc.’s stock price is $5.930, which is up 3.67% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Ardelyx, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Zweig Screen: 11.3% Compared to S&P 500
at only 6.9%

Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.